Schedule 13G ownership disclosure

CUE BIOPHARMA INC

Common Stock, $0.001 par value per share · CUSIP: 22978P106

Event date: 2022-11-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Mark E. Strome

    Shares: 2,166,242.00 · Class: 4.99%

  • Strome Mezzanine Fund, LP

    Shares: 46,103.00 · Class: 0.11%

  • Strome Mezzanine Fund II, LP

    Shares: 1,907,281.00 · Class: 4.39%

  • Strome Dynasty, LLC.

    Shares: 162,629.00 · Class: 0.38%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-044863
Form type
SCHEDULE 13G/A
Filer
Cue Biopharma, Inc.
CIK
CIK 1645460
Filed
May 16, 2025
Reporting period
Nov 14, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub